Newsletter

Vectrus Systems Receives $45 Million Contract Award for Naval Support Facility in Romania

On May 15, Vectrus Systems, Corp., a wholly owned subsidiary of Vectrus, Inc. (VEC), announced that it was awarded a new $45 million contract with the U.S. Navy. Vectrus will provide base operations support services at the Naval Support Facility in Deveselu, Romania through May 2028. This is the third new contract that the U.S. […]

0Comments

Ultragenyx Reports Positive Initial Data on DTX401 Clinical Trial

On May 15, Ultragenyx Pharmaceutical Inc. (RARE) presented positive initial data from all three cohorts in its DTX401 clinical trial. DTX401 is an adeno-associated virus-based gene therapy. It is undergoing clinical trials for the treatment of glycogen storage disease type 1a (GSD1a). All patients demonstrated significant cornstarch reductions over time and increases in time to […]

0Comments

Kratos Awarded Sole-Source Contract from U.S. Space Force

On May 4, Kratos Defense & Security Solutions, Inc. (KTOS) announced that it was awarded a sole-source contract with the U.S. Space Force. Under the terms of the contract, Kratos will provide satellite bandwidth utilization services and continuous monitoring of commercial satellites leased by the U.S. Space Force. The contract is valued at just over […]

0Comments

Akebia Announces Positive Phase 3 Clinical Trial Results

Akebia Therapeutics, Inc. (AKBA) announced positive top-line results on May 5 for the first of its two Phase 3 cardiovascular outcomes programs. The two INNO2VATE studies evaluated the efficacy and safety of Akebia’s drug vadadustat. The drug treats anemia due to chronic kidney disease in adult patients on kidney dialysis. The studies indicate that the treatment […]

0Comments

FDA Grants Accelerated Approval to Immunomedics for Trodelvy in Breast Cancer Patients

On April 22, Immunomedics, Inc. (IMMU) announced that they received accelerated FDA approval of Trodelvy™ (sacituzumab govitecan-hziy) for the treatment of adult patients with metastatic triple-negative breast cancer (TNBC). The treatment is specifically for patents who have received at least two prior therapies for metastatic disease. This is a particularly aggressive form of cancer for […]

0Comments

Diana Shipping Enters Time Charter Contract with C Transport Maritime

On April 13, Diana Shipping Inc. (DSX) announced that it entered into a time charter contract with C Transport Maritime Ltd. The contract for the m/v Houston began on April 13 and will continue through July 1, 2021. The contract could be extended through September 30, 2021. C Transport Maritime agreed to pay a gross […]

0Comments

GenMark Diagnostics Provides Preliminary Financials for First Quarter and Increases Guidance for 2020

On April 7, GenMark Diagnostics, Inc. (GNMK) provided preliminary financial results for the quarter ending March 31, 2020. During the first quarter, GenMark received FDA emergency use authorization for its ePlex SARS-CoV-2 Test. Total revenue estimates for the first quarter are $38.7 million, which is an 80% increase over the first quarter of 2019. GenMark […]

0Comments

Scientific Games Wins 10-year Iowa Lottery Contract

Scientific Games Corporation (SGMS) announced on April 7 that the company won a new 10-year contract with the Iowa Lottery. Scientific Games will provide a new statewide gaming system for the 2,400 retail locations where Iowa Lottery games are sold. Over the last eight years, Scientific Games has helped the Iowa Lottery to increase sales […]

0Comments